65 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
35
High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators.
University of California
21
Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases.
University of California
12
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis.
Istituto Giannina Gaslini
4
¿F508-CFTR correctors: synthesis and evaluation of thiazole-tethered imidazolones, oxazoles, oxadiazoles, and thiadiazoles.
Wuhan University of Science and Technology
35
Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator.
Vertex Pharmaceuticals
2
A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
Universite Grenoble Alpes
1
ABSOLUTE CONFIGURATION AND BIOLOGICAL PROPERTIES OF ENANTIOMERS OF CFTR INHIBITOR BPO-27.
University of California
118
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
University of Oxford
23
Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.
University of California
4
An expeditious access to 5-pyrimidinol derivatives from cyclic methylglyoxal diadducts, formation of argpyrimidines under physiological conditions and discovery of new CFTR inhibitors.
University Joseph Fourier-Grenoble 1/Cnrs
26
Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.
University of California
43
Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis.
University of California
7
Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.
Istituto Italiano di Tecnologia (IIT)
76
Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis.
Abbvie
23
Recent advances in triazole synthesis via click chemistry and their pharmacological applications: A review.
National Forensic Sciences University
5
Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains.
St. Jude Children'S Research Hospital
3
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis.
University of Palermo
5
Synthesis and Biological Evaluation of Pyrazole-Pyrimidones as a New Class of Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
University of Padova
15
Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms.
China Pharmaceutical University
19
Facilitating the development of molecular glues: Opportunities from serendipity and rational design.
Sichuan University
22
Overview of CFTR activators and their recent studies for dry eye disease: a review.
Shenyang Pharmaceutical University
3
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5.
University of Bologna
47
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector.
Galapagos
34
A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives.
China Pharmaceutical University
43
Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-
Yonsei University
6
Novel Substituted Cyclopropyl Compounds as CFTR Modulators for Treating Cystic Fibrosis.
Smith, Gambrell & Russell
16
Discovery and SAR of 4-aminopyrrolidine-2-carboxylic acid correctors of CFTR for the treatment of cystic fibrosis.
Abbvie
43
Discovery of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid diamides that increase CFTR mediated chloride transport.
Genzyme
147
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Central South University
31
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Novartis Institutes For Biomedical Research
8
Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels.
Université
5
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library.
National Research Council (Itb-Cnr)
22
3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators.
University of California
18
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis.
Galapagos
3
Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity.
University of Poitiers
41
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1
D3-Pharmachemistry
33
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays.
University of Genoa
2
Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosis.
Rccs Istituto Giannina Gaslini
6
Targeting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein for the Treatment of Cystic Fibrosis.
Therachem Research Medilab (India)
30
Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review.
Y. B. Chavan College of Pharmacy
17
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis.
Abbvie
19
Novel Hits in the Correction of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis.
Siena Biotech
23
Constrained bithiazoles: small molecule correctors of defective ΔF508-CFTR protein trafficking.
University of California
5
Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.
University of California Davis
14
Structure-activity relationships of cyanoquinolines with corrector-potentiator activity in ΔF508 cystic fibrosis transmembrane conductance regulator protein.
University of California Davis
3
Fluorinated ΔF508-CFTR correctors and potentiators for PET imaging.
University of California Davis
10
Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.
University of California Davis
9
4'-Methyl-4,5'-bithiazole-based correctors of defective delta F508-CFTR cellular processing.
University of California
1
Asperidines A-C, pyrrolidine and piperidine derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178.
Prince of Songkla University
9
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein.
Usona Institute
92
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools.
University of Genoa
17
Synthesis and anticholinergic activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety.
Tehran University of Medical Sciences
24
Substituted indanes, method for the production thereof, and use thereof as drugs
Sanofi